AVROBIO Inc
NASDAQ:TECX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AVROBIO Inc
NASDAQ:TECX
|
US |
|
Morgan Stanley
NYSE:MS
|
US |
|
M
|
Microchip Technology Inc
XMUN:MCP
|
US |
|
Barrick Mining Corp
SIX:B
|
CA |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
Advanced Info Service PCL
SET:ADVANC
|
TH |
|
B
|
Bank of America Corp
F:NCB
|
US |
|
W
|
WesBanco Inc
NASDAQ:WSBC
|
US |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
|
Bit Digital Inc
NASDAQ:BTBT
|
US |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
B
|
Barratt Developments P L C
F:3BA
|
UK |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
M
|
Morgan Stanley
XMUN:DWD
|
US |
|
W
|
WesBanco Inc
F:WEY
|
US |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
W
|
WP Carey Inc
F:WPY
|
US |
|
M
|
McCormick & Company Inc
F:MCX
|
US |
|
C
|
Canadian Pacific Railway Ltd
F:PC8
|
CA |
Bankruptcy Probability
AVROBIO Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AVROBIO Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
AVROBIO Inc
NASDAQ:TECX
|
691.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AVROBIO Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AVROBIO Inc has total debt of 17k USD. This includes both short-term (0 USD) and long-term (17k USD) debt.
You can find a full breakdown on its Balance Sheet.
